Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate

Marie-Hélène Canron1, Martine Perret, Anne Vital

  • 1Univ. de Bordeaux, Institut des Maladies Neurodégénératives , UMR 5293, F-33000 Bordeaux, France.

Scientific Reports
|December 4, 2012
PubMed

Insights

Mouse lemur primates naturally develop alpha-synuclein aggregates with age, mirroring human synucleinopathies. This finding suggests Microcebus murinus as a valuable model for studying age-related diseases like Alzheimer's and Parkinson's.

Area of Science:

  • Neuroscience
  • Primate Models
  • Aging Research

Background:

  • Age-dependent amyloid-beta deposition is known in Microcebus murinus.
  • This suggests potential for modeling other age-related neurological disorders.

Purpose of the Study:

  • To investigate Microcebus murinus as a model for age-related synucleinopathy.
  • To characterize the distribution of alpha-synuclein and its modified forms in aging primate brains.

Main Methods:

  • Brain tissue analysis of Microcebus murinus aged 1.5 to 10 years.
  • Characterization of amyloid-beta, alpha-synuclein, phospho-Ser129 alpha-synuclein, and nitrated alpha-synuclein.

Main Results:

  • Intracytoplasmic alpha-synuclein aggregates were found exclusively in aged animals.
  • These aggregates were immunoreactive for phospho-Ser129 and nitrated alpha-synuclein.
  • Age-dependent alpha-synuclein aggregation occurs spontaneously in this primate model.

Conclusions:

  • Microcebus murinus exhibits spontaneous, age-dependent alpha-synuclein aggregation.
  • This primate species serves as a potential model for studying age-associated synucleinopathies.
  • It may also be useful for preclinical testing of therapeutics for Alzheimer's and Parkinson's diseases.

Related Concept Videos